Electroconvulsive therapy for malignant catatonia in adolescence.
Malignant catatonia is a severe form of catatonia which is acute in onset, and is systemically devastating, as it is associated with fever and autonomic instability. Although rarely described in children and adolescents, malignant catatonia should feature prominently in the differential diagnosis of acute pediatric encephalopathies, as it is a treatable syndrome. The case of a 17-year-old adolescent with sickle cell anemia is presented. The patient developed malignant catatonia and responded dramatically to electroconvulsive therapy.
Dhossche
Dirk M
DM
Department of Psychiatry, University of Mississippi Medical Center, Jackson, MS 39216, USA. dr6340451@pol.net
Shettar
Shashidhar M
SM
Kumar
Tarun
T
Burt
Laura
L
D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis
D014151:Anti-Anxiety Agents; D008140:Lorazepam